Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Connective and Soft Tissue Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Connective and Soft Tissue Neoplasm

Cancer Family

Connective and Soft Tissue Neoplasm

CI-CAN-00000010Explore in graph →

Non-malignant848 active trials17 approved drugs339 evidence items

NCIt: C3810
MeSH: D018204

Overview
Statistics
Survival
Genomics24
Variants & evidence339
Drugs43
Trials3877
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (225)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 26–50 of 225 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The genomic landscape of pediatric Ewing sarcoma.
· Cancer Discov · 2014 · PMID 25186949 · validated civic_curation pubmed
Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12).
· Cancer Genet Cytogenet · 1988 · PMID 3163261 · validated civic_curation pubmed
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
· J Clin Oncol · 2008 · PMID 18955451 · validated civic_curation pubmed
Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
· Am J Pathol · 2008 · PMID 18832571 · validated civic_curation pubmed
CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
· Mod Pathol · 2012 · PMID 22766794 · validated civic_curation pubmed
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.
· Nat Genet · 2013 · PMID 24162739 · validated civic_curation pubmed
Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
· Genes Chromosomes Cancer · 2012 · PMID 22034177

Showing 26–50 of 225 publications

← Previous
1
2
3
…
9
Next →

· validated civic_curation

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.

· J Clin Oncol · 2002 · PMID 12039929 · validated civic_curation pubmed

Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.

· Pathol Int · 2012 · PMID 23252872 · validated civic_curation pubmed

Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion.

· Am J Clin Pathol · 2013 · PMID 24124145 · validated civic_curation pubmed

Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma.

· Clin Cancer Res · 2020 · PMID 31615936 · validated civic_curation pubmed

β-Catenin mutation status and outcomes in sporadic desmoid tumors.

· Oncologist · 2013 · PMID 23960186 · validated civic_curation pubmed

Specificity of fusion genes in adipocytic tumors.

· Anticancer Res · 2010 · PMID 20332486 · validated civic_curation pubmed

MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.

· Mod Pathol · 2016 · PMID 27562493 · validated civic_curation pubmed

Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).

· Mod Pathol · 2009 · PMID 19561568 · validated civic_curation pubmed

BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.

· Mod Pathol · 2015 · PMID 25360585 · validated civic_curation pubmed

Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.

· Am J Surg Pathol · 2017 · PMID 28346326 · validated civic_curation pubmed

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.

· J Clin Oncol · 2021 · PMID 34166060 · validated civic_curation pubmed

Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.

· Hum Pathol · 2008 · PMID 17950782 · validated civic_curation pubmed

Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.

· Ann Surg Oncol · 2015 · PMID 25341748 · validated civic_curation pubmed

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.

· Oncogene · 2001 · PMID 11244503 · validated civic_curation pubmed

Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney.

· Nat Genet · 2015 · PMID 26098867 · validated civic_curation pubmed

Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.

· Hum Pathol · 2012 · PMID 21835426 · validated civic_curation pubmed

TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.

· Am J Surg Pathol · 2016 · PMID 26975036 · validated civic_curation pubmed

A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.

· Am J Surg Pathol · 2016 · PMID 26501226 · validated civic_curation pubmed